You'd think that with 18 years' experience in the field, the doc would have worked out that RGT i a short-term proposition at best.
Maybe there is a set up for SK-Pharma group to take over RGT in the near future - I notice the doc has not relinquished his "day job" at SK-Pharma group.
Ann: Argent BioPharma Appoints Dr Shlomo Sadoun to Advisory Board, page-2
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.010(2.74%) |
Mkt cap ! $16.98M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 37.0¢ | $1.174K | 3.139K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2959 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 2200 | 1 |
View Market Depth
| Last trade - 13.03pm 21/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |